Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RESPOND-IL17: Fiber Supplementation in Axial Spondyloarthritis
NCT05812157Completed
- Sponsor
- CHU Nîmes
- Start
- Oct 2023
- Primary completion
- Feb 2026
- Countries
- 1
01
Overview
Randomised trial in axial spondyloarthritis (axSpA) (2 arms), sponsored by CHU Nîmes. Primary endpoint: Changes in Clostridiales bacteria at 12 weeks. Started Oct 2023; status: completed.
02
Conditions
axial spondyloarthritis (axSpA)
Beyond the preview
Go deeper on NCT05812157.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05812157.